FAST study demonstrates high diagnostic accuracy of CAAS vFFR and received USA 510(k) market clearance.

Esaote SpA announces the completion of the acquisition of its share capital by a Consortium of leading Chinese investors.

New investor is a consortium of leading chinese healthcare companies and financial sponsors.

26th August 2017 [Barcelona, Spain] ‐ Esaote has the pleasure to support the ESC 2017, European Cardiovascular Congress (Barcelona, Spain ‐ August 26th‐30th)

Esaote presents his experience on the Chinese market in the meeting organized by the Liguria Region with a delegation from Guangdong.

Ebit (Esaote Group) and Siemens Healthineers signed an important partnership to resell Suitestensa, the Ebit software dedicated to cardiology

Today Esaote S.p.A. (www.esaote.com) opened a new plant for the company’s research and production of dedicated MRI systems in Genoa Multedo

At the historical headquarter in Via di Caciolle, Florence – Esaote S.p.A., leader in the biomedical electronics sector, inaugurated its new Centre of Excellence for Probes

Chicago, Illinois 27 November 2016 - Esaote, one of the world leaders in the manufacturing of medical imaging equipment, introduces the MyLab^™Eight Ultrasound System* at RSNA 2016...

Chicago, Illinois 27 November 2016 - Esaote, one of the world leaders in the manufacturing of medical imaging equipment, introduces the MyLab^™Six CrystaLine at the Radiology Society of North America...

North Wales Glan Clwyd Hospital is the first NHS Hospital to invest in a weight-bearing MRI scanner...

INDIANAPOLIS, – Esaote North America, Inc. announced today that Larry Dentice...

Esaote receives FDA clearance to market and sell its Virtual Navigator fusion...

Washington DC, March 28, 2014 – At the 63rd Annual Scientific Session of the American College of Cardiology, Esaote is demonstrating new CrystaLine imaging...

To better prepare cardiovascular ultrasound students to compete and thrive in the evolving healthcare environment, Oregon Institute of Technology (Oregon Tech) ...